Clinical Trials Logo

Clinical Trial Summary

This is a multi-center, open-label study to assess the efficacy and safety of Flebogamma 5% DIF in the pediatric population.


Clinical Trial Description

n/a


Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00634569
Study type Interventional
Source Grifols Biologicals Inc.
Contact
Status Completed
Phase Phase 4
Start date May 2008
Completion date May 2011